Clinical TrialsSearch results
Number of results: 335
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Treatment of olfactory dysfunction by Topical Application of Basic Fibroblast Growth Factor
- olfactory disorder
- Hato Naohito
- 2024-08-14
Recruiting
- Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors
- EC; HNSCC; PDAC; CRC; HCC ; Ad-eso/GEJ/Gastric; Non-squamous NSCLC; UC
- Inoguchi Akihiro
- 2024-04-05
Recruiting
- A Phase I, Open label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti tumor Effects of Recombinant Oncolytic Virus M1 (M1 c6v1) for Treatment of Patients with Locally Advanced or Metastatic Solid Tumors
- Solid Tumors
- Sawai Yoshihito
- 2023-12-15
Recruiting
- CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease
- Breast Cancer, Early Breast Cancer
- Hibi Kazushige
- 2023-11-11
Recruiting
- Zimberelimab and domvanalimab in combination with chemotherapy versus pembrolizumab with chemotherapy in patients with untreated metastatic non-small cell lung cancer
- Non-small Cell Lung Cancer
- Ali Nasermoaddeli
- 2023-11-10
Completed
- Phase II clinical study of TR-012001 in Japanese patients with Parkinson's disease
- Parkinson's disease
- Kanazashi Shuichi
- 2023-10-12
Not yet recruiting
- Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5)
- Multiple Myeloma
- Ishibashi Hideyasu
- 2023-09-12
Completed
- Interventional, exploratory, open-label trial of Lu AF28996 in Japanese men and women with Parkinson's disease
- Parkinson's disease
- Yazawa Masanari
- 2023-08-12
Other
- Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
- Small Cell Lung Cancer (SCLC)
- Tagashira Shuzo
- 2023-08-04
Recruiting
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)
- advanced or metastatic GEA, including gastric, GEJ, and esophageal adenocarcinomas.
- Sakanishi Ryuichi
- 2023-06-19